Abbott MediaRoom http://abbott.mediaroom.com/ Abbott Initiates Study to Evaluate Ablation as a Frontline Treatment for Patient's Suffering from a Common but Complex Cardiac Arrhythmia http://abbott.mediaroom.com/2018-11-20-Abbott-Initiates-Study-to-Evaluate-Ablation-as-a-Frontline-Treatment-for-Patients-Suffering-from-a-Common-but-Complex-Cardiac-Arrhythmia LESS-VT Study is the first U.S. clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic ventricular tachycardia, a common heart rhythm disorder Tue, 20 Nov 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-11-20-Abbott-Initiates-Study-to-Evaluate-Ablation-as-a-Frontline-Treatment-for-Patients-Suffering-from-a-Common-but-Complex-Cardiac-Arrhythmia New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant http://abbott.mediaroom.com/2018-11-15-New-Approvals-Allow-Chronic-Pain-Sufferers-to-Try-Abbotts-Non-Opioid-Pain-Therapy-Before-Getting-Device-Implant - Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful Thu, 15 Nov 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-11-15-New-Approvals-Allow-Chronic-Pain-Sufferers-to-Try-Abbotts-Non-Opioid-Pain-Therapy-Before-Getting-Device-Implant Abbott and The Chertoff Group Explore Current State of Cybersecurity in the Connected Hospital http://abbott.mediaroom.com/2018-11-15-Abbott-and-The-Chertoff-Group-Explore-Current-State-of-Cybersecurity-in-the-Connected-Hospital New White Paper Shares Research Findings on Perceptions and Awareness of Medical Device Cybersecurity, Need for Collaboration to Address Cybersecurity Challenges Thu, 15 Nov 2018 08:40:00 -0500 http://abbott.mediaroom.com/2018-11-15-Abbott-and-The-Chertoff-Group-Explore-Current-State-of-Cybersecurity-in-the-Connected-Hospital Abbott Recommends Rejection of Below-Market Mini-Tender Offer by Baker Mills LLC http://abbott.mediaroom.com/2018-11-14-Abbott-Recommends-Rejection-of-Below-Market-Mini-Tender-Offer-by-Baker-Mills-LLC Wed, 14 Nov 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-11-14-Abbott-Recommends-Rejection-of-Below-Market-Mini-Tender-Offer-by-Baker-Mills-LLC Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results http://abbott.mediaroom.com/2018-10-25-Abbott-Introduces-the-Next-Generation-of-Influenza-A-B-and-Strep-A-Assays-with-Fastest-Ever-Time-to-Molecular-Results NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT Thu, 25 Oct 2018 09:00:00 -0400 http://abbott.mediaroom.com/2018-10-25-Abbott-Introduces-the-Next-Generation-of-Influenza-A-B-and-Strep-A-Assays-with-Fastest-Ever-Time-to-Molecular-Results